Study finds rapid genome sequencing boosts pediatric diagnoses at Seattle Children's
Go back to Study finds rapid genome sequencing boosts pediatric diagnoses at Seattle Children's| (NASDAQ: WGS) | Delayed: 97.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $97.83 | 52 Week High | $ | |||
| Open | $97.83 | 52 Week Low | $ | |||
| Day High | $97.83 | P/E | N/A | |||
| Day Low | $97.83 | EPS | $ | |||
| Volume | 1,658 | |||||
